# Autologous Blood Monocyte Vesicles for the Treatment of Sudden Deafness

> **NCT06707389** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University** · enrollment: 30 (estimated)

## Conditions studied

- Sudden Deafness
- Sensorineural Hearing Loss

## Interventions

- **BIOLOGICAL:** autologous blood monocyte vesicles (lower dose)
- **DRUG:** Methylprednisolone
- **BIOLOGICAL:** autologous blood monocyte vesicles (higher dose)

## Key facts

- **NCT ID:** NCT06707389
- **Lead sponsor:** Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-25
- **Primary completion:** 2026-06-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06707389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06707389, "Autologous Blood Monocyte Vesicles for the Treatment of Sudden Deafness". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06707389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*